儿童因心动过缓伴灌注不良接受心肺复苏时使用肾上腺素与更差结局相关
该研究利用Get With The Guidelines-Resuscitation登记数据库,纳入2000年1月至2018年12月期间因心动过缓伴灌注不良(非无脉性事件)接受院内心肺复苏的≤18岁儿童患者。采用时间依赖倾向评分匹配,将复苏最初10分钟内接受肾上腺素的患者与同一分钟内存在接受肾上腺素风险的患者进行匹配,共匹配3528对。作者结论认为肾上腺素与更差结局相关,但研究不能排除潜在混杂。
要点
- 在因心动过缓伴灌注不良接受心肺复苏的儿童中,肾上腺素与出院生存率降低相关(RR 0.79,95%CI 0.74-0.85;p<0.001)。
- 肾上腺素与24小时生存率降低相关(RR 0.85,95%CI 0.81-0.90;p<0.001)。
- 肾上腺素与有利神经结局降低相关(RR 0.76,95%CI 0.68-0.84;p<0.001)。
- 肾上腺素与进展为无脉性风险增加相关(RR 1.17,95%CI 1.06-1.28;p<0.001)。
适用人群与场景
- ≤18岁儿童患者,因心动过缓伴灌注不良(非无脉性事件)接受院内心肺复苏,数据来自Get With The Guidelines-Resuscitation登记数据库,时间为2000年1月至2018年12月。
研究设计与关键结果
- 研究类型为基于Get With The Guidelines-Resuscitation登记数据库的队列研究,采用时间依赖倾向评分匹配。
- 全队列中55%为男性,39%为新生儿;接受肾上腺素的患者在事件前需要血管升压药和机械通气的数量多于未接受肾上腺素的患者。
- 共3528例接受肾上腺素的患者与3528例基于倾向评分存在接受肾上腺素风险的患者匹配。
- 肾上腺素与出院生存率降低相关(RR 0.79,95%CI 0.74-0.85;p<0.001)。
- 肾上腺素与24小时生存率降低相关(RR 0.85,95%CI 0.81-0.90;p<0.001)。
- 肾上腺素与有利神经结局降低相关(RR 0.76,95%CI 0.68-0.84;p<0.001)。
- 肾上腺素与进展为无脉性风险增加相关(RR 1.17,95%CI 1.06-1.28;p<0.001)。
证据类型、等级与局限
- 证据类型:基于登记数据库的队列研究,采用时间依赖倾向评分匹配。
- 作者结论认为肾上腺素与更差结局相关,但研究不能排除潜在混杂。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在因心动过缓伴灌注不良接受心肺复苏的儿童中,使用肾上腺素与出院生存率、自主循环恢复、24小时生存率及有利神经结局降低相关,并与进展为无脉性风险增加相关;作者结论认为肾上腺素与更差结局相关,但研究不能排除潜在混杂。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 3 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
AIM: To determine whether the use of epinephrine in pediatric patients receiving cardiopulmonary resuscitation for bradycardia and poor perfusion was associated with improved clinical outcomes.
METHODS: Using the Get With The Guidelines-Resuscitation registry, we included pediatric patients (≤18 years) who received in-hospital cardiopulmonary resuscitation for bradycardia with poor perfusion (non-pulseless event) between January 2000 and December 2018. Time-dependent propensity score matching was used to match patients receiving epinephrine within the first 10 min of resuscitation to patients at risk of receiving epinephrine within the same minute.
RESULTS: In the full cohort, 55% of patients were male and 39% were neonates. A higher number of patients receiving epinephrine required vasopressors and mechanical ventilation prior to the event compared to those not receiving epinephrine. A total of 3528 patients who received epinephrine were matched to 3528 patients at risk of receiving epinephrine based on the propensity score. Epinephrine was associated with decreased survival to hospital discharge (RR, 0.79 [95% CI, 0.74-0.85]; p < 0.001), return of spontaneous circulation (RR, 0.94 [95% CI, 0,91-0.96]; p < 0.001), 24-h survival (RR, 0.85 [95% CI, 0.81-0.90]; p < 0.001), and favorable neurological outcome (RR, 0.76 [95% CI, 0.68-0.84]; p < 0.001). Epinephrine was also associated with an increased risk of progression to pulselessness (RR, 1.17 [95% CI, 1.06-1.28]; p < 0.001).
CONCLUSION: In children receiving cardiopulmonary resuscitation for bradycardia with poor perfusion, epinephrine was associated with worse outcomes, although the study does not eliminate the potential for confounding.
参考来源
- Holmberg MJ, Ross CE, Yankama T, et al. Epinephrine in children receiving cardiopulmonary resuscitation for bradycardia with poor perfusion. Resuscitation. 2020. PMID: 31926260. doi:10.1016/j.resuscitation.2019.12.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。